Pathology Outlines - p63
Webpathology.com: A Collection of Surgical Pathology Images
p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
Pathology Outlines - p63
A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text
Expression of TTF-1, p63 in lung cancer (Envision two-step method,... | Download Scientific Diagram
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations - ScienceDirect
Cureus | Accuracy of Classifying Lung Carcinoma Using Immunohistochemical Markers on Limited Biopsy Material: A Two-Center Study | Article
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
p63 IHC analysis with 4A4 antibody in lung tumorigenesis. A , bronchial... | Download Scientific Diagram
TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
p63, 2X (Lung) - Biocare Medical
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
P63 - RMAB086R - Diagnostic BioSystems(dbiosys) DBS
Diagnostics | Free Full-Text | TTF-1/p63-Positive Poorly Differentiated NSCLC: A Histogenetic Hypothesis from the Basal Reserve Cell of the Terminal Respiratory Unit
Frontiers | Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases
Immunohistochemistry stains in squamous cell carcinoma and... | Download Scientific Diagram
p63 in different subtypes of lung carcinoma | Download Scientific Diagram
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
